These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 37495886)
1. Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies. Finze A; Biechele G; Rauchmann BS; Franzmeier N; Palleis C; Katzdobler S; Weidinger E; Guersel S; Schuster S; Harris S; Schmitt J; Beyer L; Gnörich J; Lindner S; Albert NL; Wetzel CH; Rupprecht R; Rominger A; Danek A; Burow L; Kurz C; Tato M; Utecht J; Papazov B; Zaganjori M; Trappmann LK; Goldhardt O; Grimmer T; Haeckert J; Janowitz D; Buerger K; Keeser D; Stoecklein S; Dietrich O; Morenas-Rodriguez E; Barthel H; Sabri O; Bartenstein P; Simons M; Haass C; Höglinger GU; Levin J; Perneczky R; Brendel M Mol Psychiatry; 2023 Oct; 28(10):4438-4450. PubMed ID: 37495886 [TBL] [Abstract][Full Text] [Related]
2. Associations between sex, body mass index and the individual microglial response in Alzheimer's disease. Biechele G; Rauchmann BS; Janowitz D; Buerger K; Franzmeier N; Weidinger E; Guersel S; Schuster S; Finze A; Harris S; Lindner S; Albert NL; Wetzel C; Rupprecht R; Rominger A; Palleis C; Katzdobler S; Burow L; Kurz C; Zaganjori M; Trappmann LK; Goldhardt O; Grimmer T; Haeckert J; Keeser D; Stoecklein S; Morenas-Rodriguez E; Bartenstein P; Levin J; Höglinger GU; Simons M; Perneczky R; Brendel M J Neuroinflammation; 2024 Jan; 21(1):30. PubMed ID: 38263017 [TBL] [Abstract][Full Text] [Related]
3. Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer's disease: a longitudinal study. Nabizadeh F; Seyedmirzaei H; Karami S Sci Rep; 2024 Jul; 14(1):15318. PubMed ID: 38961148 [TBL] [Abstract][Full Text] [Related]
4. Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathology. Suárez-Calvet M; Morenas-Rodríguez E; Kleinberger G; Schlepckow K; Araque Caballero MÁ; Franzmeier N; Capell A; Fellerer K; Nuscher B; Eren E; Levin J; Deming Y; Piccio L; Karch CM; Cruchaga C; Shaw LM; Trojanowski JQ; Weiner M; Ewers M; Haass C; Mol Neurodegener; 2019 Jan; 14(1):1. PubMed ID: 30630532 [TBL] [Abstract][Full Text] [Related]
5. Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge. Cousins O; Schubert JJ; Chandra A; Veronese M; Valkimadi P; Creese B; Khan Z; Arathimos R; Hampshire A; Rosenzweig I; Ballard C; Corbett A; Aasland D; Velayudhan L; O'Neill M; Collier D; Awais R; Sander K; Årstad E; Howes O; Turkheimer F; Hodges A J Neuroinflammation; 2023 Nov; 20(1):272. PubMed ID: 37990275 [TBL] [Abstract][Full Text] [Related]
6. In vivo positron emission tomographic imaging of glial responses to amyloid-beta and tau pathologies in mouse models of Alzheimer's disease and related disorders. Maeda J; Zhang MR; Okauchi T; Ji B; Ono M; Hattori S; Kumata K; Iwata N; Saido TC; Trojanowski JQ; Lee VM; Staufenbiel M; Tomiyama T; Mori H; Fukumura T; Suhara T; Higuchi M J Neurosci; 2011 Mar; 31(12):4720-30. PubMed ID: 21430171 [TBL] [Abstract][Full Text] [Related]
8. Microglial Activation and Connectivity in Alzheimer Disease and Aging. Rauchmann BS; Brendel M; Franzmeier N; Trappmann L; Zaganjori M; Ersoezlue E; Morenas-Rodriguez E; Guersel S; Burow L; Kurz C; Haeckert J; Tatò M; Utecht J; Papazov B; Pogarell O; Janowitz D; Buerger K; Ewers M; Palleis C; Weidinger E; Biechele G; Schuster S; Finze A; Eckenweber F; Rupprecht R; Rominger A; Goldhardt O; Grimmer T; Keeser D; Stoecklein S; Dietrich O; Bartenstein P; Levin J; Höglinger G; Perneczky R Ann Neurol; 2022 Nov; 92(5):768-781. PubMed ID: 36053756 [TBL] [Abstract][Full Text] [Related]
9. Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer's Disease Continuum. Chen YH; Lin RR; Huang HF; Xue YY; Tao QQ Front Aging Neurosci; 2022; 14():848180. PubMed ID: 35847667 [TBL] [Abstract][Full Text] [Related]
10. Microglia measured by TSPO PET are associated with Alzheimer's disease pathology and mediate key steps in a disease progression model. Rossano SM; Johnson AS; Smith A; Ziaggi G; Roetman A; Guzman D; Okafor A; Klein J; Tomljanovic Z; Stern Y; Brickman AM; Lee S; Kreisl WC; Lao P Alzheimers Dement; 2024 Apr; 20(4):2397-2407. PubMed ID: 38298155 [TBL] [Abstract][Full Text] [Related]
11. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia. Lodder C; Scheyltjens I; Stancu IC; Botella Lucena P; Gutiérrez de Ravé M; Vanherle S; Vanmierlo T; Cremers N; Vanrusselt H; Brône B; Hanseeuw B; Octave JN; Bottelbergs A; Movahedi K; Dewachter I Acta Neuropathol Commun; 2021 Jun; 9(1):108. PubMed ID: 34103079 [TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal Fluid sTREM2 in Alzheimer's Disease Is Associated with Both Amyloid and Tau Pathologies but not with Cognitive Status. Li TR; Lyu DY; Liu FQ; J Alzheimers Dis; 2022; 90(3):1123-1138. PubMed ID: 36213998 [TBL] [Abstract][Full Text] [Related]
13. Glial activation and inflammation along the Alzheimer's disease continuum. Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945 [TBL] [Abstract][Full Text] [Related]
14. sTREM2 is associated with amyloid-related p-tau increases and glucose hypermetabolism in Alzheimer's disease. Biel D; Suárez-Calvet M; Hager P; Rubinski A; Dewenter A; Steward A; Roemer S; Ewers M; Haass C; Brendel M; Franzmeier N; EMBO Mol Med; 2023 Feb; 15(2):e16987. PubMed ID: 36620941 [TBL] [Abstract][Full Text] [Related]
15. Microglial Reactivity Correlates with Presynaptic Loss Independent of β-Amyloid and Tau. Lan G; Chen X; Yang J; Sun P; Cai Y; Li A; Zhu Y; Liu Z; Ma S; Guo T; Ann Neurol; 2024 May; 95(5):917-928. PubMed ID: 38356322 [TBL] [Abstract][Full Text] [Related]
16. The relationship between the morphological subtypes of microglia and Alzheimer's disease neuropathology. Paasila PJ; Davies DS; Kril JJ; Goldsbury C; Sutherland GT Brain Pathol; 2019 Nov; 29(6):726-740. PubMed ID: 30803086 [TBL] [Abstract][Full Text] [Related]
17. sTREM2 is associated with attenuated tau aggregate accumulation in the presence of amyloid-β pathology. Nabizadeh F Brain Commun; 2023; 5(6):fcad286. PubMed ID: 37942087 [TBL] [Abstract][Full Text] [Related]
18. Microglia in Alzheimer's Disease in the Context of Tau Pathology. Perea JR; Bolós M; Avila J Biomolecules; 2020 Oct; 10(10):. PubMed ID: 33066368 [TBL] [Abstract][Full Text] [Related]
19. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Streit WJ; Braak H; Xue QS; Bechmann I Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731 [TBL] [Abstract][Full Text] [Related]